Data / Form D filings / Sarcio, Inc.
Sarcio, Inc.: Form D filings
Sarcio, Inc., a biotechnology company in St. Paul, MN, filed 2 Form D notices with the SEC in 2023. The latest, on August 14, 2023, reports $785,336 sold of a $850,000 offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13675 GURNEY PATH, St. Paul, MN, 55124
- Phone
- (612) 360-3958
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1856247
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | New notice | $850,000 | $785,336 | $64,664 | 23 | Mar 5, 2021 | sec.gov |
| Jul 17, 2023 | New notice | $750,000 | $607,503 | $142,497 | 13 | Dec 21, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Beth Lindborg | Executive Officer, Director | |
| Michael Williams | Director | |
| Amanda Vegoe | Executive Officer | |
| Marc Tompkins | Executive Officer | |
| Timothy O'Brien | Executive Officer, Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sarcio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.